Scott Wilson is an assistant professor of biomedical engineering and the director of the Wilson Laboratory for Biomaterials Synthesis and Immunoengineering.
Scott’s research focuses on the synthesis and preclinical validation of biomaterials-based immunomodulatory therapies that bias the adaptive immune response towards immunity or tolerance. Utilizing organic chemistry, the aim of Scott’s group is to synthesize bespoke biomaterials with specific immunomodulatory functionalities. In particular, Scott is interested in the development of immunity-inducing therapies for the treatment of malignancy and infectious disease as well as tolerance-induction strategies that knock out the antigen-specific immune responses driving autoimmunity, transplant rejections, and the immunogenicity of protein-based therapeutics. In addition to immunomodulatory therapies, Scott’s lab is also interested in platforms that modulate the spatial-temporal delivery of both small molecules and biologics.
He earned his BS and MS in chemical engineering from the University of Oklahoma, and his PhD in chemical engineering and bioengineering from the Georgia Institute of Technology.